Altered responsiveness of serotonin receptor subtypes following long-term cannabinoid treatment.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  International Journal of Neuropsychopharmacology

• Publication date

  2006-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1017/S1461145705005651PMID 15967059
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 5-HT1A receptor function in depression: effect of chronic amitriptyline treatment

  2005cited by this paper
• Effect of ACTH, adrenalectomy and the combination treatment on the density of 5-HT2 receptor binding sites in neocortex of rat forebrain and 5-HT2 receptor-mediated wet-dog shake behaviors

  2005cited by this paper
• Functional role of the endocannabinoid system and AMPA/kainate receptors in 5-HT2A receptor-mediated wet dog shakes.

  2005cited by this paper
• Serotonergic Stimulation of the Rat Hypothalamo‐Pituitary‐Adrenal Axis: Interaction between 5‐HT1A and 5‐HT2A Receptors

  2004cited by this paper
• Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use.

  2004cited by this paper
• Anatomic and Functional Topography of the Dorsal Raphe Nucleus

  2004cited by this paper
• Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635

  2004cited by this paper
• Long-lasting effects of chronic stress on DOI-induced hyperthermia in male rats

  2003cited by this paper
• Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover.

  2003cited by this paper
• Exploring the association between cannabis use and depression.

  2003cited by this paper
• The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions

  2003cited by this paper
• Prenatal ethanol exposure in rats alters serotonergic-mediated behavioral and physiological function

  2002cited by this paper
• Involvement of 5-hydroxytryptamine neuronal system in Delta(9)-tetrahydrocannabinol-induced impairment of spatial memory.

  2002cited by this paper
• Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice.

  2001cited by this paper
• 5-HT1A and 5-HT2 receptors differentially regulate the excitability of 5-HT-containing neurones of the guinea pig dorsal raphe nucleus in vitro.

  2001cited by this paper
• Cannabis abuse as a risk factor for depressive symptoms.

  2001cited by this paper
• Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment.

  2000cited by this paper
• Blunted temperature and cortisol responses to ipsapirone in major depression: lack of enhancement by electroconvulsive therapy.

  2000cited by this paper
• Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.

  1999cited by this paper
• PET imaging of serotonin 1A receptor binding in depression.

  1999cited by this paper
• A review of central 5-HT receptors and their function.

  1999cited by this paper
• Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors

  1999cited by this paper
• Behavioral Effects of Cannabinoid Agents in Animals.

  1999cited by this paper
• Chronic stress effects on sexual behavior in male and female rats: mediation by 5-HT2A receptors.

  1998cited by this paper
• Sexual behavior and wet dog shakes in the male rat: regulation by corticosterone.

  1998cited by this paper
• Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide.

  1998cited by this paper
• Molecular Psychiatry

  1998cited by this paper
• Effects of corticosterone on 5-HT1A and 5-HT2 receptor binding and on the receptor-mediated behavioral responses of rats.

  1997influential reference
• Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.

  1997influential reference
• Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal.

  1997cited by this paper
• Decreased 5-HT1A and increased 5-HT2A receptor binding after chronic corticosterone associated with a behavioural indication of depression but not anxiety.

  1997cited by this paper
• Modulation of 5-HT receptor subtype-mediated behaviours by corticosterone.

  1996cited by this paper
• Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis.

  1996cited by this paper
• Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.

  1996cited by this paper
• Effects of 8-OH-DPAT on corticosterone after acute and chronic administration of antidepressants.

  1995cited by this paper
• 5-HT1A and 5-HT2 receptors mediate hypo- and hyperthermic effects of tryptophan in pargyline-pretreated rats.

  1995cited by this paper
• Effects of ipsapirone on plasma cortisol and body temperature in major depression.

  1995cited by this paper
• Serotonergic control of the organization of feeding and satiety.

  1995cited by this paper
• 5-HT1A Receptor Sensitivity in Major Depression

  1994cited by this paper
• Electrophysiological evidence for a functional interaction between 5‐HT1A and 5‐HT2A receptors in the rat medial prefrontal cortex: An lontophoretic study

  1994influential reference
• Suppression of experimental autoimmune encephalomyelitis by cannabinoids.

  1994cited by this paper
• Serotonergic mechanisms in anxiety.

  1994cited by this paper
• A slow excitatory postsynaptic potential mediated by 5-HT2 receptors in nucleus prepositus hypoglossi

  1994cited by this paper
• 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala.

  1993cited by this paper
• The effects of corticosterone on 5-HT receptor function in rodents.

  1992cited by this paper
• Concurrent wet dog shaking and inhibition of male rat copulation after ventromedial brainstem injection of the 5-HT2 agonist DOI.

  1992cited by this paper
• Characterization of the 5‐HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5‐HT agonists in rats

  1991influential reference
• Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

  1991cited by this paper
• Inhibition of 5-HT2 receptor-mediated head-twitch response by cocaine via indirect stimulation of adrenergic alpha 2 and serotonergic 5-HT1A receptors.

  1991cited by this paper
• 5-HT1A receptor responsivity in anxiety disorders and depression.

  1991cited by this paper
• 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex.

  1991cited by this paper
• 5-HT1A receptor responsivity in anxiety disorders and depression

  1991cited by this paper
• Behavioural evidence for a functional interaction between central 5‐HT2 and 5‐HT1A receptors

  1990cited by this paper
• Subsensitivity of the 5-hydroxytryptamine1A (5-HT1A) receptor-mediated hypothermic response to ipsapirone in unipolar depression.

  1990cited by this paper
• 5-HT1A receptor responsivity in unipolar depression. Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls.

  1990cited by this paper
• Serotonin Receptor Subtypes and Sexual Behavior a

  1990cited by this paper
• Do functional relationships exist between 5-HT1A and 5-HT2 receptors?

  1990cited by this paper
• Involvement of 5‐HT2 receptors in the behaviours produced by intrathecal administration of selected 5‐HT agonists and the TRH analogue (CG 3509) to rats

  1989cited by this paper
• Evidence for the 5-HT Hypothesis of Suicide A Review of Post-mortem Studies

  1989cited by this paper
• Long-term cortisol treatment impairs behavioral and neuroendocrine responses to 5-HT1 agonists in the rat.

  1989cited by this paper
• Serotonin-induced head shaking behavior in rats does not involve receptors located in the frontal cortex.

  1987cited by this paper
• In mice repeated administration of electroconvulsive shock or desmethylimipramine produces rapid alterations in 5-HT2-mediated head-twitch responses and cortical 5-HT2 receptor number.

  1986cited by this paper
• 5‐HT2 receptor characteristics in frontal cortex and 5‐HT2 receptor‐mediated head‐twitch behaviour following antidepressant treatment to mice

  1984cited by this paper
• Behavioral and biochemical effects of chronic Δ9-tetrahydrocannabinol in rats

  1980cited by this paper
• Behavioral and biochemical effects of chronic delta 9-tetrahydrocannabinol in rats.

  1980cited by this paper
• "Wet-dog" shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity.

  1977cited by this paper
• Endocrine effects of chronic intraventricular administration of delta9-tetrahydrocannabinol to prepuberal and adult male rats.

  1976cited by this paper
• TOLERANCE TO THE EFFECT OF Δ1‐TETRAHYDROCANNABINOL ON CORTICOSTERONE LEVELS IN MOUSE PLASMA PRODUCED BY REPEATED ADMINISTRATION OF CANNABIS EXTRACT OR Δ1‐TETRAHYDROCANNABINOL

  1974cited by this paper
• Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.

  1974cited by this paper

• Trends in the diagnostic prevalence of cannabis-related disorders and co-occurring psychiatric disorders in adolescents: analysis of German health insurance data from 2013 to 2022.

  2026cites this paper
• Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data

  2026cites this paper
• Association between marijuana and depression: Exploring the mediating role of environmental pollutants.

  2025cites this paper
• The impact of piperazine and antipsychotic co-exposures and CB1 blockade on the effects elicited by AMB-FUBINACA, a synthetic cannabinoid, in mice.

  2024cites this paper
• Potential Implications of Multi-Drug Exposure with Synthetic Cannabinoids: A Scoping Review of Human Case Studies

  2024cites this paper
• Involvement of nucleus raphe magnus in neuronal excitability of long term paracetamol-treated rats

  2023cites this paper
• Can cannabidiol (CBD) help with low back pain?

  2023cites this paper
• Risk Factors and Clinical Correlates of Pediatric Serotonin Syndrome in Hospitalized Suicide Attempters

  2023cites this paper
• The Chronic Pharmacological Antagonism of the CB1 Receptor is not Involved in the Behavioral Effects of Antidepressants Administered in Mice Submitted to Chronic Unpredictable Stress.

  2023cites this paper
• Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis

  2022cites this paper
• The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations

  2021cites this paper
• Endocannabinoid-serotonin systems interaction in health and disease.

  2021cites this paper
• Serotonin 2A receptors and cannabinoids.

  2021cites this paper
• Cannabidiol reduces the latency for the behavioral effect of escitalopram in chronically stressed male mice: involvement of NAPE-PLD expressed in parvalbumin-positive interneurons and the prefrontal cortex

  2021cites this paper
• Drugs of Abuse Affecting 5-HT2B Receptors

  2021cites this paper
• Cannabinoids and sleep-wake cycle: The potential role of serotonin.

  2021cites this paper
• Synergistic antidepressant- and anxiolytic-like effects of harmaline along with cinanserin in acute restraint stress-treated mice

  2020cites this paper
• Interaction of Cannabis Use and Aging: From Molecule to Mind

  2020cites this paper
• Reduction and Cessation of Alcohol, Cannabis, and Stimulant Use: Prospective Associations With Changes in Depressive Symptoms Across Two Cohort Studies of Sexual and Gender Minorities.

  2020cites this paper
• Cannabis Improves Obsessive-Compulsive Disorder—Case Report and Review of the Literature

  2020cites this paper
• Serotonin Syndrome versus Cannabis Toxicity in the Emergency Department

  2020cites this paper
• The association of cannabis use and cardiac dysrhythmias: a systematic review

  2020cites this paper
• Comorbid Cannabis Use Disorder with Major Depression and Generalized Anxiety Disorder: A Systematic Review with Meta-analysis of Nationally Representative Epidemiological Surveys.

  2020cites this paper
• Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies

  2020cites this paper
• MODULATORY EFFECT OF CANNABINOID LIGANDS ON THE ANXIETY-LIKE BEHAVIOR OF BULBECTOMIZED RATS

  2019cites this paper
• Modulatory effects of cannabinoids on brain neurotransmission

  2019cites this paper
• Repeated Exposure to the “Spice” Cannabinoid JWH-018 Induces Tolerance and Enhances Responsiveness to 5-HT1A Receptor Stimulation in Male Rats

  2018influential citation
• The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal

  2018cites this paper
• Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity

  2018cites this paper
• Cannabinoid-induced lower lip retraction in rats

  2018cites this paper
• Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway

  2018cites this paper
• Changes in the Brain Endocannabinoid System in Rat Models of Depression

  2017cites this paper
• A little “dab” will do ya’ in: a case report of neuro-and cardiotoxicity following use of cannabis concentrates

  2017cites this paper
• Cannabis: A Treasure Trove or Pandora's Box?

  2017cites this paper
• Emotion regulation deficits in regular marijuana users

  2017cites this paper
• Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic nervous system?

  2017cites this paper
• Effects of Psychotropic Drugs on Seizure Threshold during Electroconvulsive Therapy

  2017cites this paper
• Modeling the Positive Symptoms of Schizophrenia

  2016cites this paper
• EFFECT OF N-ACETYL-PARA-AMINOPHENOL (PARACETAMOL) AND HEAVY CANNABIS USE ON EXERCISE PERFORMANCE, METABOLIC PARAMETERS AND NEURO-COGNITIVE FUNCTION IN HUMANS

  2016cites this paper
• Effects of Δ9-Tetrahydrocannabinol, Synthetic Cannabinoids, and Fatty Acid Amide Hydrolase Inhibitors on Mood and Serotonin Neurotransmission

  2016cites this paper
• Serotonergic neurotransmission in emotional processing: New evidence from long-term recreational poly-drug ecstasy use

  2016cites this paper
• Vilazodone for cannabis dependence: A randomized, controlled pilot trial.

  2016cites this paper
• The involvement of medial septum 5-HT1 and 5-HT2 receptors on ACPA-induced memory consolidation deficit: Possible role of TRPC3, TRPC6 and TRPV2

  2015cites this paper
• Associations of Cannabis and Cigarette Use with Depression and Anxiety at Age 18: Findings from the Avon Longitudinal Study of Parents and Children

  2015cites this paper
• Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial.

  2015cites this paper
• The role of endocannabinoid function in posttraumatic stress disorder: Modulating the risk phenotype and rendering effects of trauma

  2015cites this paper
• Paracetamol potentiates the antidepressant-like and anticompulsive-like effects of fluoxetine

  2015cites this paper
• Synthetic Cannabis Substances (SPS) Use and Hallucinogen Persisting Perception Disorder (HPPD): Two Case Reports.

  2014cites this paper
• Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.

  2014cites this paper
• Hallucinogen persisting perception disorder and the serotonergic system: a comprehensive review including new MDMA-related clinical cases.

  2014cites this paper
• The effect of chronic adolescent cannabinoid exposure on adult sexual behaviour

  2014cites this paper
• Lack of interaction of endocannabinoids and 5-HT(3) neurotransmission in associative fear circuits of the amygdala: evidence from electrophysiological and behavioural experiments.

  2013cites this paper
• Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders

  2013cites this paper
• Involvement of Serotonergic System in Cannabinoid Analgesia

  2013cites this paper
• Pathophysiology of Mood Disorders and Mechanisms of Action of Antidepressants and Mood Stabilizers

  2013cites this paper
• Cannabinoid-induced upregulation of serotonin 2A receptors in the hypothalamic paraventricular nucleus and anxiety-like behaviors in rats.

  2013influential citation
• Cannabinoid 2 receptor- and beta Arrestin 2-dependent upregulation of serotonin 2A receptors.

  2013cites this paper
• Modulation of Serotonin Firing Activity Through CB1 Agonists and FAAH Inhibitors

  2013cites this paper
• Cannabinoid Regulation of Serotonin 2A (5-HT 2A ) Receptor Signaling

  2013cites this paper
• Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5‐HT2A) receptor activity via ERK1/2 signaling

  2013influential citation
• Cannabis and depression: an integrative data analysis of four Australasian cohorts.

  2012influential citation
• Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase.

  2012cites this paper
• Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts

  2012cites this paper
• Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.

  2012cites this paper
• Cannabinoid-induced enhanced interaction and protein levels of serotonin 5-HT2A and dopamine D2 receptors in rat prefrontal cortex

  2012cites this paper
• Structural plasticity of the serotonergic and dopaminergic systems : a multidisciplinary approach

  2012cites this paper
• Benign and time-limited visual disturbances (flashbacks) in recent abstinent high-potency heavy cannabis smokers: a case series study.

  2011cites this paper
• Altered expression of neuronal tryptophan hydroxylase-2 mRNA in the dorsal and median raphe nuclei of three genetically modified mouse models relevant to depression and anxiety.

  2011cites this paper
• New strategies in the development of antidepressants: towards the modulation of neuroplasticity pathways.

  2011cites this paper
• Explaining associations between cannabis use disorders in adolescence and later major depression: a test of the psychosocial failure model.

  2011cites this paper
• Male-female differences in the effects of cannabinoids on sexual behavior and gonadal hormone function.

  2010cites this paper
• Long-Term Fluoxetine Treatment Modulates Cannabinoid Type 1 Receptor-Mediated Inhibition of Adenylyl Cyclase in the Rat Prefrontal Cortex through 5-Hydroxytryptamine1A Receptor-Dependent Mechanisms

  2010cites this paper
• Genetic Deletion of Fatty Acid Amide Hydrolase Alters Emotional Behavior and Serotonergic Transmission in the Dorsal Raphe, Prefrontal Cortex, and Hippocampus

  2010cites this paper
• Precipitated withdrawal counters the adverse effects of subchronic cannabinoid administration on male rat sexual behavior.

  2010cites this paper
• Altered CB1 receptor‐signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine

  2009cites this paper
• Endocannabinoids in the treatment of mood disorders: evidence from animal models.

  2009cites this paper
• Depersonalization: Towards a pharmacology of depersonalization

  2009cites this paper
• Depersonalization: Psychological approaches to the treatment of depersonalization disorder

  2009cites this paper
• OF ADENYLYL CYCLASE IN THE RAT PREFRONTAL CORTEX THROUGH 5-HT1A RECEPTOR-DEPENDENT MECHANISMS

  2009cites this paper
• Altered affective response in marijuana smokers: an FMRI study.

  2009cites this paper
• A placebo-controlled trial of buspirone for the treatment of marijuana dependence.

  2009cites this paper
• Role of endocannabinoid signaling in anxiety and depression.

  2009cites this paper
• No association between chronic cannabis use and loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission.

  2009cites this paper
• Depersonalization disorder: pharmacological approaches

  2008cites this paper
• Effects of Dietary Fatty Acids on Endocannabinoid Signaling in the Brain and Peripheral Organs

  2008cites this paper
• Cannabinoid CB1 receptor antagonists in therapeutic and structural perspectives.

  2008cites this paper
• The effect of concomitant ecstasy-marijuana use on auditory verbal learning and memory performance

  2007cites this paper
• Enhancement of endocannabinoid signalling during adolescence: Modulation of impulsivity and long-term consequences on metabolic brain parameters in early maternally deprived rats.

  2007cites this paper
• Serotonergic vulnerability and depression: assumptions, experimental evidence and implications

  2007cites this paper
• CB1 knockout mice display impaired functionality of 5‐HT1A and 5‐HT2A/C receptors

  2007cites this paper
• PRECLINICAL STUDY: Effect of cannabinoids on platelet serotonin uptake

  2007cites this paper
• Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice.

  2007cites this paper
• Cannabinoids Elicit Antidepressant-Like Behavior and Activate Serotonergic Neurons through the Medial Prefrontal Cortex

  2007cites this paper
• Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders

  2006cites this paper
• Cannabinoid-1 receptor antagonist, rimonabant, for management of obesity and related risks.

  2006cites this paper
• Increased sensitivity to restraint stress and novelty-induced emotionality following long-term, high dose cannabinoid exposure.

  2006cites this paper
• Chronic Delta9-tetrahydrocannabinol administration affects serotonin levels in the rat frontal cortex.

  2006cites this paper
• Involvement of the Endocannabinoid System in the Ability of Long-Term Tricyclic Antidepressant Treatment to Suppress Stress-Induced Activation of the Hypothalamic–Pituitary–Adrenal Axis

  2006cites this paper
• Chronic Δ9-tetrahydrocannabinol administration affects serotonin levels in the rat frontal cortex

  2005cites this paper